Document is current
Any future updates will be listed below
-
Authors
Zhang, Wenhao
Kwiecinski, Jacek
Shanbhag, Aakash
Miller, Robert J. H.
Mostafavi, Shiva
Ramirez, Giselle
Yi, Jirong
Han, Donghee
Dey, Damini
Grodecka, Dominika
Grodecki, Kajetan
Lemley, Mark
Kavanagh, Paul
Liang, Joanna X.
Zhou, Jianhang
Builoff, Valerie
Hainer, Jon
Carre, Sylvain
Barrett, Leanne
Einstein, Andrew J.
Knight, Stacey
Mason, Steve
Le, Viet T.
Acampa, Wanda
Wopperer, Samuel
Chareonthaitawee, Panithaya
Berman, Daniel S.
Di Carli, Marcelo F.
Slomka, Piotr J.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R35HL161195)
National Institute of Biomedical Imaging and Bioengineering (R01EB034586)
- License Information
-
More Information
Article History
Received: 19 June 2025
Accepted: 1 January 2026
First Online: 14 January 2026
Competing interests
: Robert J.H. Miller received consulting fees and research support from Pfizer. Daniel S. Berman, Piotr J. Slomka, and Paul B. Kavanagh participated in software royalties for QPS software at Cedars-Sinai Medical Center. Piotr S. Slomka has received consulting fees from Synektik. Damini Dey, Piotr J Slomka and Daniel S. Berman have equity interest in APQ Health. Daniel S. Berman has served as a consultant for GE Healthcare. Andrew J. Einstein has received speaker fees from Ionetix, consulting fees from Artrya and W. L. Gore & Associates, and authorship fees from Wolters Kluwer Healthcare. Andrew J. Einstein has also served on scientific advisory boards for Canon Medical Systems and Synektik S.A. and received grants to Columbia University from Alexion, Attralus, BridgeBio, Canon Medical Systems, Eidos Therapeutics, Intellia Therapeutics, International Atomic Energy Agency, Ionis Pharmaceuticals, National Institutes of Health, Neovasc, Pfizer, Roche Medical Systems, Shockwave Medical, and W. L. Gore & Associates. Marcelo F. Di Carli reports on institutional research grants from Gilead Sciences, Xylocor, Sun Pharma, Intellia Therapeutics, Alnylam Pharmaceuticals, and Amgen. He also receives consulting fees from MedTrace, Valo Health, and IBA. The remaining authors declare no competing interests.
